DrugPatentWatch Database Preview
Drugs in MeSH Category Sympathomimetics
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 212520-001 | Jul 8, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Recordati Rare | DESOXYN | methamphetamine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 005378-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Neos Theraps | ADZENYS XR-ODT | amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 204326-006 | Jan 27, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Par Pharm Inc | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 207169-001 | Oct 29, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hikma Intl Pharms | DOPAMINE HYDROCHLORIDE | dopamine hydrochloride | INJECTABLE;INJECTION | 207707-001 | Apr 11, 2018 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Abraxis Pharm | DOPAMINE HYDROCHLORIDE | dopamine hydrochloride | INJECTABLE;INJECTION | 070012-001 | Jun 12, 1985 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
